Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieHumansPolyestersCapsule OpacificationLensesIntraocular
An intraocular lens coated with polycaprolactone and methotrexate as a slow-release system for prophylaxis of posterior capsule opacification in-vitro.
Christina Hilterhaus, Arne J Speidel, Simone C Felis, Anna Hillenmayer, Armin Wolf, Christian M Wertheimer
Published: 202510.1016/j.biopha.2025.118693
Abstract
PURPOSE: Posterior capsule opacification (PCO) is the most common postoperative complication after cataract surgery. As a pharmacological prophylaxis, we designed a drug-carrying slow-release intraocular lens (IOL) implant coated with polycaprolacton…
Preview only. Read the full abstract at the source